症状性颈动脉狭窄患者的药物治疗结局
药物治疗组随访期同侧缺血性卒中发生率4.8%,1年无卒中生存率药物与手术组均为94%,但药物治疗组总生存率低于手术组。
要点
- 症状性颈动脉狭窄药物治疗组同侧卒中风险较低,与手术组无卒中生存率相当。
- 药物治疗组总生存率低于接受颈动脉干预的患者。
- 需更大样本研究确认药物与手术治疗症状性颈动脉狭窄的长期结局。
核心结论
- 接受干预的症状性颈动脉疾病患者生存更好,但未来同侧卒中事件风险与仅药物治疗患者似乎相当。
研究设计与样本
- 前瞻性观察研究,单中心三级血管转诊中心,研究期2019年6月1日至2024年1月1日,共280例症状性颈动脉狭窄患者。
主要发现
- 药物治疗组中3例(4.8%)随访期发生同侧缺血性卒中。
- 药物治疗与手术治疗1年及4年无卒中生存率分别为94% vs 94%和88% vs 88%。
- 药物治疗组与颈动脉干预组1年及4年总生存率分别为88%和57% vs 97%和88%。
关键数值与推荐
- 症状性颈动脉狭窄手术干预阈值设为狭窄≥70-99%(依据学会指南)。
临床怎么用
- 对于症状性颈动脉狭窄患者,药物治疗可考虑用于特定人群,但需权衡总生存率低于手术干预的风险。
局限性
- 单中心观察性研究,样本量有限,需更大规模研究确认长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Level 1 evidence recommends that carotid endarterectomy (CEA) should be considered for symptomatic >50% internal carotid artery stenosis for stroke prevention. However, there is little contemporary data on the natural history of patients with symptomatic carotid artery stenosis who were managed with medical therapy alone. The aim of this study was to assess the outcomes of patients with symptomatic carotid artery stenosis who were managed medically. METHODS: This was a prospective observational study at a tertiary vascular referral center. The study period was from June 1, 2019, to January 1, 2024. Threshold for surgical intervention in patients with a symptomatic internal carotid artery was set at a stenosis of ≥70-99% as defined by societal guidelines. The primary outcome was stroke-free survival and all-cause mortality. Kaplan-Meier analysis was performed to assess stroke-free survival and all-cause mortality. RESULTS: There were 280 patients who were referred for management of symptomatic carotid artery stenosis during the study period. One-hundred fifty patients (69.4%) were treated with a CEA, 3 patients (1.4%) with carotid artery stenting, and the remaining 63 patients (29.2%) were managed medically. Of the patients managed medically, three patients (4.8%) developed a further ipsilateral ischemic stroke during the follow-up period. Any stroke-free survival for medically versus surgically managed patients at 1 and 4 years were both 94% vs. 94% and 88%, respectively. Overall, the medically managed patient group survival compared with those who had carotid intervention at 1 and 4 years were 88% and 57% vs. 97% and 88%, respectively. CONCLUSION: Patients who underwent intervention for symptomatic carotid disease have better survival; however, risk of future ipsilateral stroke events appear to be comparable with patients who had medical management only. Larger studies are warranted to confirm the long-term outcomes between carotid surgery and medical management in symptomatic carotid artery stenosis.
引用
- Lim ETA, Ying G, Bernau O, et al. Medical Management of Patients With Symptomatic Carotid Artery Stenosis. Ann Vasc Surg. 2025. PMID: 41242381. doi:10.1016/j.avsg.2025.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。